Why is Peoples Bancorp stock sliding today?

Peoples Bancorp shares fell 5.5% to $36.72 after announcing a $728.1 million all-stock acquisition of Capital Bancorp, with Capital holders to receive 1.11 Peoples shares per share. The transaction, expected to close in H1 2027, would create a bank with about $14 billion in assets, $10 billion in loans and $11 billion in deposits, but investors are pricing in dilution, tangible-book-value pressure and regulatory execution risk. A shareholder-rights law firm also opened an investigation into the sale process, adding legal uncertainty. Softer-than-expected August PCE inflation—3.4% headline versus 3.7% expected and 3.0% core versus 3.3% expected—provided a modest macro tailwind but did not offset deal-related selling.

Analysis

The relevant valuation question is not headline dilution but whether PEBO can earn back tangible-book dilution within a market-acceptable period. Without disclosed cost saves, purchase-accounting marks, pro forma CET1, and tangible-book earnback, the initial selloff should not be assumed to be an overreaction; subscale bank combinations often fail to receive multiple credit until management quantifies those items. A weak PEBO share price also mechanically lowers consideration received by CBNK holders under the fixed exchange ratio, creating a feedback loop in which PEBO-specific selling pressure can widen the merger-arbitrage discount.

The cleaner opportunity is conditional merger arbitrage rather than directional regional-bank exposure. If CBNK trades materially below 1.11x PEBO after adjusting for borrow, dividends, and the unusually long closing timeline, long CBNK/short 1.11 PEBO isolates completion risk while avoiding duration exposure to regional-bank multiples and Fed expectations. The extended approval window makes annualized spread returns potentially attractive only if the gross spread is wide enough to compensate for regulatory, shareholder-vote, and integration uncertainty; a generic plaintiff-firm inquiry is not itself a material deal-break signal.

Over the next 1-3 months, PEBO needs to publish the transaction economics before a durable rerating is plausible. The key falsifiers for a bearish PEBO view are a tangible-book earnback below roughly three years, credible cost saves that make the deal meaningfully EPS accretive in year one, and pro forma capital comfortably above management buffers. Over 6-18 months, softer rates could help securities marks and capital ratios but may simultaneously compress asset yields; the combined deposit franchise only merits a higher multiple if deposit costs prove structurally lower than peers rather than merely larger in absolute terms.

Key Decisions for Investors

• Set a merger-arbitrage alert: initiate long CBNK / short 1.11 shares PEBO only if the annualized gross spread exceeds 10-12% after estimated borrow and dividend carry. Size modestly given the expected H1 2027 close; exit if the spread tightens below 4-5% annualized or regulatory timing slips materially.
• Do not add directional PEBO exposure solely on the announcement-day decline. Reassess after the proxy or investor presentation discloses cost saves, EPS accretion, pro forma CET1, and tangible-book earnback; a sub-three-year earnback with conservative credit marks would support covering any PEBO underweight.
• For existing PEBO holders, hedge regional-bank beta rather than liquidating into an information vacuum: short a proportionate KRE position through the next transaction-model disclosure, while retaining PEBO-specific exposure. Remove the hedge if management demonstrates deposit-cost advantages and capital accretion versus similarly sized regional-bank peers.
• Monitor CBNK’s trading price versus the live implied value of 1.11x PEBO daily. A persistent discount despite normal liquidity would be the actionable signal; without that price and borrow data, there is no basis for recommending the pair trade.